Celestica (CLS)

• Market cap: $11.1B
• 1 day: 2.58%
• 5 days: -4.51%
• 1 month: 9.74%
• 3 months: 95.88%
• 6 months: 71.06%
• Year to date: 237.64%
• 1 year: 232.81%
• 5 years: 1,030.92%
• 10 years: 728.56%

About: Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Employees: 26,554

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

122% more call options, than puts

Call options by funds: $298M | Put options by funds: $134M

13% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 64

12% more repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 117

2% more funds holding

Funds holding: 337 [Q2] → 345 (+8) [Q3]

6.6% less ownership

Funds ownership: 74.5% [Q2] → 67.9% (-6.6%) [Q3]

11% less funds holding in top 10

Funds holding in top 10: 19 [Q2] → 17 (-2) [Q3]

19% less capital invested

Capital invested by funds: $5.07B [Q2] → $4.13B (-$940M) [Q3]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $68 29% downside
• Avg. target: $82 15% downside
• High target: $100 5% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

Stifel Matthew Sheerin 58% 1-year accuracy 15 / 26 met price target	5% upside $100	Buy Maintained	10 Dec 2024
UBS David Vogt 45% 1-year accuracy 5 / 11 met price target	0% downside $95	Neutral Initiated	22 Nov 2024
Barclays George Wang 56% 1-year accuracy 9 / 16 met price target	5% downside $91	Overweight Initiated	5 Nov 2024
TD Cowen Daniel Chan 75% 1-year accuracy 3 / 4 met price target	27% downside $70	Buy Maintained	24 Oct 2024
RBC Capital Paul Treiber 86% 1-year accuracy 12 / 14 met price target	21% downside $75	Outperform Maintained	24 Oct 2024